- Replimune Group Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Replimune Group Inc RP1 Program Update Call TranscriptDec 05, 2023
- Replimune Group Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Replimune Group Inc to Host Virtual Investor Event TranscriptDec 07, 2022
- Replimune Group Inc To Host Investor Day TranscriptMar 30, 2022
- Replimune Group Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Replimune Group Inc Annual Shareholders Meeting TranscriptSep 08, 2021
- Replimune Group Inc Virtual Investor Event Corporate Call TranscriptJun 03, 2021
- Replimune Group Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Replimune Group Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Replimune Group Inc to Provide Phase 1/2 Clinical Data Update on Patients with Melanoma and Non-Melanoma Skin Cancers - Conference Call TranscriptJun 03, 2020
- Replimune Group Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
Replimune Group Inc Annual Shareholders Meeting Transcript
Good afternoon. I'm Dieter Weinand, Chairman of the Board of Directors of the company. Will the meeting please come to order?
Let me take this opportunity to welcome you to the 2021 Annual Meeting of Stockholders of Replimune Group, Inc. We're looking forward to hosting this meeting in a virtual format this year in light of the ongoing health concerns associated with COVID 19.
At this time, I would like to introduce you to Shawn Glidden the Vice President, Legal Affairs, Compliance Officer and Secretary of the company, who is present virtually today, and will act as Secretary for the meeting. I would also like to note that representatives of Morgan Lewis and Bakes LLP, counsel to the company; and PricewaterhouseCoopers LLP, the company's independent registered public accountants are also present virtually today at the meeting.
Before proceeding to the business of this meeting, there are certain legal matters which we must dispose of in order to make certain that we are conducting a duly authorized
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)